Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Wilmington Group Names Pedro Ros CEO - Quick Facts

Wilmington Group Plc. (WIL.L) said Pedro Ros would join the Board of Wilmington on July 14 and would assume the role of Group Chief Executive on October 1, following the publication of the Group's preliminary 2014 results and completion of the associated investor roadshow.

This follows the announcement of Charles Brady's retirement made on February 25.

Ros, 52, was until June 2012 CEO and then Chairman of TNS, a global subsidiary of advertising giant WPP Plc.

From January 2006 until the acquisition of TNS by WPP in October 2008, Ros was executive director of Taylor Nelson Sofres plc, and Managing Director, TNS Global Clients & Sectors.

Ros is Head of Strategic Insight at Creston plc, the digitally focused insight and communications group, a role which he will relinquish on June 13.

Click here to receive FREE breaking news email alerts for Wilmington Group and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.